Archived Story

LA biotech billionaire enters Covid-19 vaccine race

primary article image

PermaLink

Jon Cohen

Science

Related: healthleadersmedia

Top News

Reckoning: how US failed in coronavirus pandemic

primary article image

PermaLink

Chuck Todd

NBC

Related: CNN, TIME (US magazine), Aging Cell

Remdesivir, just received conditional approval in EU for COVID-19, faces global supply shortage. Gilead criticized for placing most drugs to US. Germany has only a few hundred doses. An inhaled form of the drug being tested

primary article image

PermaLink

Matt Mathers

The Independent (London, England)

Related: Express Pharma, yahoo

Moderna, the lead US biotech firm on COVID-19 vaccine with no track record, reportedly fighting with government scientists on COVID-19 vaccine trials, announces completion of phase 2 study enrollment (600 patients), confirms to launch phase 3 in July

primary article image

PermaLink

Marisa Taylor

Reuters

Related: BARRON's, @CMichaelGibson, Moderna, Inc., Fierce Biotech, Wall Street Journal

Regeneron starts separate phase 3 clinical trials of its double-antibody cocktail for Covid-19 treatment & prevention, signs a $450 MM contract with U.S. government for 70K-300K treatment doses or 420K-300K prevention doses

primary article image

PermaLink

Reuters Staff

CNBC

Related: CNN

Grim prediction by Fauci: 100,000 new Covid-19 cases a day in the US, if no change on the pandemic course

primary article image

PermaLink

William Feuer

CNBC

Related: Axios, @DrEricDing, @WSJ, NBC

The first COVID-19 vaccine approved in China for military use after completing phase 1 & phase 2 clinical trials

primary article image

PermaLink

Reuters Editorial

Reuters

Related: @DrEricDing, @ScottGottliebMD, @globaltimesnews, @CE_ChinaEconomy

As US & the World struggling to battle the coronavirus pandemic, a hopeful note - Congo declares the world’s 2nd-worst Ebola outbreak over

primary article image

PermaLink

Abdi Latif Dahir

New York Times

Related: @WHO, @DrTedros, Wall Street Journal

Race for COVID-19 vaccines, massive yet complicated and very different efforts by US (Operation Warp Speed), WHO (Solidarity), and China

primary article image

PermaLink

Jon Cohen

Science

Related: World Health Organization, The Hill, South China Morning Post

MIT ends contract with Elsevier on open access to research papers, joining Univ. of California, SUNY, & all German universities to cease subscriptions due to the publisher's high fees on scientific papers

Institute ends negotiations for a new journals contract in the absence of a proposal aligning with the MIT Framework for Publisher Contracts

PermaLink

Staff Writer

MIT NEWS

Related: @StevenSalzberg1

COVID-19 vaccine: Moderna to start a 30,000 people trial in July; J&J to start a 1,045-people trial in July, 2 months ahead of its initial plan; China to start its vaccine trial in 9,000 Brazilians

PermaLink

LAURAN NEERGAARD

ABC News

Related: Business Insider

Ambitious clinical trials started by Regeneron for its dual-antibody cocktail coronavirus drug for both prevention & treatment, combining phase I, phase II, & phase III together to accelerate the development

PermaLink

Michael Woyton

Yahoo

Related: @AndyBiotech, YouTube

WHO clarifies comments on the rarity of asymptomatic transmission of Covid-19

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: YouTube, STAT

Covid-19 vaccine: Trump administration chose five candidates as finalists: Moderna, Oxford University-AstraZeneca, Johnson & Johnson, Merck, & Pfizer. More US government funding to be provided to the finalists to speed up vaccine development

primary article image

PermaLink

Noah Weiland

New York Times

Related: @NIHDirector, @realDonaldTrump, National Geographic

Research shows attacking blood vessel by coronavirus might be the triggering factor for the peculiar and deadly nature of the disease. Such attack causes vessels to leak and blood to clot in multi-organs of human body

primary article image

PermaLink

Dana G Smith

Elemental-a Medium publication

Related: Science, Nature

Clinical trial of the first human Covid-19 antibody drug started, that can potentially be a treatment for patient or prevention for healthy individuals. Developed by Eli Lilly & Vancouver-based AbCellera

primary article image

PermaLink

Matthew Herper

STAT

Related: Eli Lilly and Company

LA biotech billionaire enters Covid-19 vaccine race

primary article image

PermaLink

Jon Cohen

Science

Related: healthleadersmedia

New clinical trial shows modest benefit of remdesivir in patients with moderate COVID-19 disease, with puzzling results of 5-day treatment reached statistical significant level while 10-day treatment did not

primary article image

PermaLink

Matthew Herper

STAT

Related: CNBC

Preliminary results of the NIAID-sponsored clinical trial of remdesivir published in the New England Journal of Medicine, laying out the detailed benefits and limitations. The clinical trial is still ongoing

primary article image

PermaLink

Matthew Herper

STAT

Related: @EricTopol, CNN, New England Journal of Medicine (NEJM)

US funds AstraZeneca $1B for Oxford's Covid-19 vaccine, with 1000 people phase 1 study ongoing & 2 phase 3 studies to start in June (1000 people UK) & July (30000 people US). The company to supply 30M & 300M doses to UK & US.

primary article image

PermaLink

Vicky McKeever

CNBC

Related: @Reuters, Science Translational Medicine

Moderna's mRNA vaccine showed promising results in phase 1 trial, generated robust immune reaction, and it's dose dependent. Phase 2 to start soon with 600 people joining, and phase 3 in July with thousands of people

The company said its preliminary test in 8 healthy volunteers was safe. It is on an accelerated timetable to begin a larger human trial soon

primary article image

PermaLink

Denise Grady

New York Times

Related: @ScottGottliebMD, TIME (US magazine)

Latest News

Five months in, the U.S. hasn't succeeded in combating the pandemic

09 Jul 2020, 1:12 PM, Chuck Todd, NBC


Remdesivir: Inhaled form of coronavirus drug being tested for use outside of hospitals

09 Jul 2020, 10:19 AM, Matt Mathers, The Independent (London, England)


Gilead begins testing inhalable form of remdesivir for COVID-19

09 Jul 2020, 8:15 AM, Reuters Staff, Express Pharma


Gilead to deliver more remdesivir to Europe from autumn - WiWo

09 Jul 2020, 7:38 AM, Reuters Staff, yahoo


States with serious coronavirus problems need to consider shutting down again, Fauci says

09 Jul 2020, Madeline Holcombe, CNN


Can Biotechs Finish the Race for a Covid-19 Vaccine?

08 Jul 2020, 3:34 PM, Josh Nathan-Kazis, BARRON's


Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)

08 Jul 2020, 2:22 PM, Staff Writer, Moderna, Inc.


Moderna delay a snapshot of 'squabbles' with U.S. scientists over COVID-19 vaccine trials: Reuters

07 Jul 2020, 3:30 PM, Amirah Al Idrus, Fierce Biotech


U.S. Virus Cases Rise as Country Withdraws From WHO

07 Jul 2020, 1:51 PM, Talal Ansari, Wall Street Journal


Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials

07 Jul 2020, 1:42 PM, Marisa Taylor, Reuters


Regeneron signs a $450 million contract with the U.S. government for its coronavirus therapy

07 Jul 2020, Reuters Staff, CNBC


Covid-19 antibody drug that might treat and prevent infection enters phase 3 trial, Regeneron says

06 Jul 2020, Jacqueline Howard, CNN


Inside Moderna: The Covid Vaccine Front-Runner With No Track Record and an Unsparing CEO

01 Jul 2020, 2:27 PM, Peter Loftus, Wall Street Journal


The U.S. and U.K. Were the Two Best Prepared Nations to Tackle a Pandemic—What Went Wrong?

01 Jul 2020, 1:59 PM, Gavin Yamey, TIME (US magazine)


CDC: Coronavirus spreading too fast in U.S.

30 Jun 2020, 8:09 PM, Rebecca Falconer, Axios


Fauci: COVID-19 cases could swell to 100,000 a day if U.S. doesn't control virus

30 Jun 2020, 7:26 PM, Erika Edwards, NBC


Why the United States failed to contain COVID‐19

30 Jun 2020, 2:05 PM, Armin Nowroozpoor, Aging Cell


Dr. Anthony Fauci says U.S. coronavirus outbreak is 'going to be very disturbing,' could top 100,000 new cases a day

30 Jun 2020, William Feuer, CNBC


CanSino's COVID-19 vaccine candidate approved for military use in China

29 Jun 2020, 8:17 AM, Reuters Editorial, Reuters


Congo Declares World’s Second-Worst Ebola Outbreak Over

25 Jun 2020, 7:55 PM, Gabriele Steinhauser, Wall Street Journal